HBsAg LOSS IS HIGHER AMONG CAUCASIANS COMPARED TO ASIANS AFTER STOPPING NUCLEOS(T)IDE ANALOGUE THERAPY: RESULTS FROM A LARGE, GLOBAL, MULTI-ETHNIC COHORT OF PATIENTS WITH CHRONIC HEPATITIS B (RETRACT-B STUDY)

被引:0
|
作者
Hirode, Grishma [1 ,2 ]
Choi, Hannah S. J. [1 ]
Su, Tung-Hung [3 ]
Wong, Grace Lai-Hung [4 ]
Seto, Wai-Kay [5 ]
Van Hees, Stijn [6 ]
Papatheodorie, Margarita [7 ]
Brakenhoff, Sylvia [8 ]
Lens, Sabela [9 ,10 ]
Sarowat, Arif [1 ]
Chien, Rong-Nan [11 ]
Forns, Xavier [9 ,10 ]
Sonneveld, Milan J. [8 ]
Papatheodoridie, George [7 ]
Vanwolleghem, Thomas [6 ]
Yuen, Man-Fung [12 ]
Chan, Henry Lik Yuen [4 ]
Kao, Jia-Horng [3 ]
Hsu, Yao-Chun
Chen, Chien-Hung [13 ,14 ]
Hansen, Bettina E. [1 ,2 ]
Cornberg, Markus [15 ]
Jeng, Wen-Juei [11 ]
Janssen, Harty L. A. [16 ]
机构
[1] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
[2] Toronto Viral Hepatitis Care Network VIRCAN, Toronto, ON, Canada
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[5] Univ Hong Kong, Hong Kong, Peoples R China
[6] Antwerp Univ Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium
[7] Natl & Kapodistrian Univ Athens, Sch Med, Gen Hosp Athens Laiko, Dept Gastroenterol, Athens, Greece
[8] Erasmus MC, Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[9] Hosp Clin Barcelona, Idibaps, Barcelona, Spain
[10] Ciberehd, Barcelona, Spain
[11] Chang Gung Mem Hosp, Taoyuan, Taiwan
[12] Univ Hong Kong, Med, Hong Kong, Peoples R China
[13] E DA Hosp, Fu Jen Catholic Univ Hosp, Kaohsiung, Taiwan
[14] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[15] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[16] Univ Hlth Network, Toronto Ctr Liver Dis, Viral Hepatitis Care Network VIRCAN, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
23
引用
收藏
页码:19A / 20A
页数:2
相关论文
共 50 条
  • [41] Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study
    Yuen, Man-Fung
    Plesniak, Robert
    Lim, Seng Gee
    Tsuji, Keiji
    Diaconescu, Gheorghe
    Gadano, Adrian
    Kim, Ju Hyun
    Asselah, Tarik
    Yim, Hyung Joon
    Heo, Jeong
    Rizzardini, Giuliano
    Janssen, Harry
    Popescu, Corneliu Petru
    Petrova, Diana
    Wong, Alexander
    Indriz, Nevin
    Pojoga, Cristina
    Tanaka, Yasuhito
    Gusev, Denis
    Janczewska, Ewa
    Cremer, Jennifer
    Elston, Robert
    Lukic, Tamara
    Maynard, Lauren
    Kendrick, Stuart
    Bharania, Punam
    Campbell, Fiona
    Paff, Melanie
    Theodore, Dickens
    JOURNAL OF HEPATOLOGY, 2022, 77 : S881 - S882
  • [42] Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection not on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study
    Lim, Seng Gee
    Pojoga, Cristina
    Janssen, Harry
    Gusev, Denis
    Plesniak, Robert
    Tsuji, Keiji
    Janczewska, Ewa
    Popescu, Corneliu Petru
    Andreone, Pietro
    Hou, Jinlin
    Arbune, Manuela
    Gadano, Adrian
    Petrova, Diana
    Inoue, Jun
    Piratvisuth, Teerha
    Lim, Young-Suk
    Leerapun, Apinya
    Atsukawa, Masanori
    Jia, Ji-Dong
    Labio, Eternity
    Cremer, Jennifer
    Elston, Robert
    Lukic, Tamara
    Quinn, Geoff
    Kendrick, Stuart
    Bharania, Punam
    Campbell, Fiona
    Paff, Melanie
    Theodore, Dickens
    JOURNAL OF HEPATOLOGY, 2022, 77 : S12 - S13
  • [43] Limited Sustained Response and Lack of HBsAg Decline after Stopping Long-Term Nucleos(t)Ide Analogue Therapy in Hbeag Negative Patients with Chronic Hepatitis B: Results of a Prospective, Randomized, Open-Label Phase IV Trial
    Liem, Kin Seng
    Fung, Scott K.
    Wong, David K. H.
    Yim, Colina K.
    Noureldin, Seham
    Huang, Feng Fei
    Shah, Hemant A.
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2018, 68 : 165A - 165A
  • [44] RESULTS OF 96-WEEK FOLLOW-UP AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUE THERAPY IN CHRONIC HEPATITIS B GENOTYPE D REGION (NUCSTOP STUDY)
    Kiremitci, Sercan
    Seven, Gulseren
    Keskin, Elmas Biberci
    Koker, Ibrahim H.
    Kochan, Koray
    Senturk, Hakan
    GASTROENTEROLOGY, 2023, 164 (06) : S1361 - S1361
  • [45] Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection
    Yi-Chun Chen
    Chung-Yi Li
    Shiang-Jiun Tsai
    Yen-Chun Chen
    World Journal of Gastroenterology, 2018, (08) : 917 - 928
  • [46] Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection
    Chen, Yi-Chun
    Li, Chung-Yi
    Tsai, Shiang-Jiun
    Chen, Yen-Chun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (08) : 917 - 928
  • [47] Persistence and adherence to nucleos(t)ide analogue treatment in chronic hepatitis B: a multi-center cohort study from the Greek national e-prescription database.
    Striki, Athanasia
    Manolakopoulos, Spilios
    Triantos, Christos K.
    Papastergiou, Vasilios
    Perlepe, Nikoleta
    Zisimopoulos, Konstantinos A.
    Papazoglou, Afroditi
    Goulis, Ioannis
    Deutsch, Melanie
    Papatheodoridis, George V.
    HEPATOLOGY, 2017, 66 : 501A - 501A
  • [48] LOW INCIDENCE OF CLINICAL OUTCOMES IN PATIENTS WITH CHRONIC HBV INFECTION IN THE ERA OF NUCLEOS(T)IDE ANALOGUE (NA) THERAPY: REPORT FROM THE HEPATITIS B RESEARCH NETWORK (HBRN) ADULT COHORT STUDY
    Lok, Anna S.
    Janssen, Harry L. A.
    Lalama, Christina
    Fried, Michael W.
    Belle, Steve
    Perrillo, Robert P.
    Ghany, Marc G.
    Khalili, Mandana
    HEPATOLOGY, 2019, 70 : 580A - 581A
  • [49] Increased HBsAg reduction and relapse outcomes in HBeAg negative patients with chronic hepatitis B after nucleos (t)ide analogue withdrawal: 4.5 year follow-up of the Toronto STOP Study
    Sarowar, Arif
    Liem, Seng
    Fung, Scott K.
    Wong, David
    Feld, Jordan
    Yim, Colina
    Noureldin, Seham
    Chen, Jenny
    Hansen, Bettina
    Janssen, Harry
    JOURNAL OF HEPATOLOGY, 2022, 77 : S849 - S850
  • [50] High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleos(t)ide analogue therapy: Analysis of the Australian NA-STOP study cohort
    Hume, S.
    Wong, D.
    Yuen, M. F.
    Jackson, K.
    Bonanzinga, S.
    Vogrin, S.
    Hall, S.
    Burns, G.
    Desmond, P.
    Sundararajan, V.
    Ratnam, D.
    Levy, M.
    Lubel, J.
    Nicoll, A.
    Strasser, S.
    Sievert, W.
    Ngu, M.
    Sinclair, M.
    Meredith, C.
    Matthews, G.
    Revill, P.
    Littlejohn, M.
    Bowden, S.
    Visvanathan, K.
    Holmes, J.
    Thompson, A. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 58 - 58